Mucopolysaccharidoses Type 4A/6 Total Chondroitin Sulfate and Dermatan Sulfate with NRE (Sensi-Pro®) Quantitative, Urine
Ordering Recommendation
Aids in the diagnosis and monitoring of patients with MPS Type 4A or Type 6.
New York DOH Approval Status
Specimen Required
N/A
Urine
Transfer 0.25 mL urine to polypropylene sample tube and freeze immediately. (Min 0.15 mL)
Critical Frozen
Specimens containing preservatives or heparin
N/A
Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 1 year (3 freeze thaw cycles are acceptable)
Methodology
Liquid Chromatography-Tandem Mass Spectrometry
Performed
Tue
Reported
14-21 days
Reference Interval
By report
Interpretive Data
Refer to report.
Total Chondroitin Sulfate and Dermatan Sulfate, Urine is a sum of the internal disaccharides D0a0, D0a4, and D0a6.
NRE = Non Reducing End
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
Note
Hotline History
CPT Codes
83864
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
3003540 | MPS 4A/6 Creatinine, Urine | |
3003541 | MPS 4A/6 Urine Interpretation | |
3003546 | Chondroitin and Dermatan Sulfate, Urine | |
3003548 | a4 (MPS 6 NRE), Urine | |
3003550 | a6 (MPS 4A NRE), Urine | |
3003551 | a4/a6 Ratio, Urine | |
3005209 | EER MPS 4A/6 Urine | 11502-2 |
Aliases
- CS non-reducing end assay
- DS non-reducing end assay
- MPS 4a
- MPS 6
- MPS type 4a
- MPS type 6
- Mucopolysaccharides
- Total Chondroitin Sulfate
- Total Dermatan Sulfate